Update on Tourette Syndrome
DOI:
https://doi.org/10.25118/2763-9037.2012.v2.900Keywords:
tourette syndrome, attention deficit hyperactivity disorder, ADHD, treatmentAbstract
Tourette syndrome has been increasingly diagnosed and treated in primary care and private practices. In clinical practice, we see that most patients receive antipsychotics. This article aims to provide an update on its treatment and show that there are safer therapeutic alternatives, such as clonidine. Typical and atypical antipsychotics can be left as a second choice.
Downloads
Metrics
References
Cath DC, Hedderly T, Ludolph AG, Stern JS, Murphy T, Hartmann A, et al European clinical guidelines for Tourette syndrome and other tic disorders. Part I: assessment. Eur Child Adolesc Psychiatry. 2011 20:155-71. Erratum in: Eur Child Adolesc Psychiatry. 2011 20:377. DOI: https://doi.org/10.1007/s00787-011-0164-6
Baron-Cohen S, Scahill VL, Izaguirre J, Hornsey H, Robertson MM. The prevalence of Gilles de la Tourette syndrome in children and adolescents with autism: a large scale study. Psychol Med. 1999;29:1151-9. DOI: https://doi.org/10.1017/S003329179900896X
Altman G, Staley JD, Wener P. Children with Tourette disorder: a follow-up study in adulthood. J Nerv Ment Dis. 2009;197:305-10. DOI: https://doi.org/10.1097/NMD.0b013e3181a206b1
Jankovic J, Gelineau-Kattner R, Davidson A. Tourette’s syndrome in adults. Mov Disord. 2010;25:2171-5 DOI: https://doi.org/10.1002/mds.23199
Roessner V, Plessen KJ, Rothenberger A, Ludolph AG, Rizzo R, Skov L, et al. European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment. Eur Child Adolesc Psychiatry. 2011;20:173-96. Erratum in: Eur Child Adolesc Psychiatry. 2011;20:377. DOI: https://doi.org/10.1007/s00787-011-0163-7
Hounie AG, Rosario-Campos, Sampaio AS, Alvarenga PG, Diniz, JB, Miguel EC. “Tourette Syndrome: treatment”. In: Marazitti, D. Handbook of Child and Adolescent Psychopharmacology, 1st ed. Healthcare, 2006, p.145-94.
Scahill L, Riddle MA, King RA, Hardin MT, Rasmusson A, Makuch RW, Leckman JF. Fluoxetine has no marked effect on tic symptoms in patients with Tourette’s syndrome: a double-blind placebo-controlled study. J Child Adolesc Psychopharmacol. 1997;7:75-85. DOI: https://doi.org/10.1089/cap.1997.7.75
Passos, RBF, López, JRRA. Síndrome de Gilles de la Tourette associada ao transtorno de déficit de atenção com hiperatividade: resposta clínica satisfatória a inibidor seletivo da recaptura de serotonina e metilfenidato. J. bras. psiquiatr., 2010, 59:160-162. DOI: https://doi.org/10.1590/S0047-20852010000200013
Hauser RA, Zesiewicz TA. Sertraline-induced exacerbation of tics in Tourette’s syndrome. Mov Disord. 1995;10: 682-4. DOI: https://doi.org/10.1002/mds.870100529
Kuo SH, Jimenez-Shahed J. Topiramate in treatment of tourette syndrome. Clin Neuropharmacol. 2010; 33:32-4. DOI: https://doi.org/10.1097/WNF.0b013e3181c295c1
Jankovic J, Jimenez-Shahed J, Brown LW. A randomised, double-blind, placebo-controlled study of topiramate in the treatment of Tourette syndrome. J Neurol Neurosurg Psychiatry. 2010 ;81:70-3. Epub 2009 Sep 1. DOI: https://doi.org/10.1136/jnnp.2009.185348
Marras C, Andrews D, Sime E, Lang AE. Botulinum toxin for simple motor tics: a randomized, double-blind, controlled clinical trial. Neurology, 2001; 56: 605-10. Disponível em: <http://www.ncbi.nlm.nih.gov/pubmed/11245710 DOI: https://doi.org/10.1212/WNL.56.5.605
Downloads
Published
How to Cite
Conference Proceedings Volume
Section
License
Copyright (c) 2012 Ana Gabriela Hounie
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Debates em Psiquiatria allows the author (s) to keep their copyrights unrestricted. Allows the author (s) to retain their publication rights without restriction. Authors should ensure that the article is an original work without fabrication, fraud or plagiarism; does not infringe any copyright or right of ownership of any third party. Authors should also ensure that each one complies with the authorship requirements as recommended by the ICMJE and understand that if the article or part of it is flawed or fraudulent, each author shares responsibility.
Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) - Debates em Psiquiatria is governed by the licencse CC-By-NC
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material
The licensor cannot revoke these freedoms as long as you follow the license terms. Under the following terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes.
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
